By regulating the expression of Sphk1 and S1P, kaempferol can inhibit the NF-kb pathway, reduce the expression of the inflammatory mediators NO and PGE2, alleviate the inflammatory response of LPS-induced sepsis, and stabilize the pulmonary vascular endothelial barrier (39). The gene discussed is NFKB1; the disease is Sepsis.